CA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVECOVER ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


CA Cancer J Clin 2003; 53:245
doi: 10.3322/canjclin.53.4.245
© 2003 American Cancer Society
This Article
Right arrow Full Text Freely available
Right arrow Full Text (PDF) Freely available
Right arrow Freely available CME: Take the course for this article:
Agent Orange and Cancer: An Overview for Clinicians
Right arrow An erratum has been published
Right arrow Submit a letter to the editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Frumkin, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Frumkin, H.

Agent Orange and Cancer: An Overview for Clinicians

Howard Frumkin, MD, DrPh


Dr. Frumkin is Professor and Chair, Department of Environmental and Occupational Health, Rollins School of Public Health, Emory University, and Professor of Medicine, Emory Medical School, Atlanta, GA.

Approximately 3 million Americans served in the armed forces in Vietnam during the Vietnam War. Some of them (as well as some Vietnamese combatants and civilians, and members of the armed forces of other nations) were exposed to defoliant mixtures, including Agent Orange. Evidence suggests some lasting health effects from these exposures, including certain cancers. This article reviews the evidence on cancer risk after Agent Orange exposure. Data sources include studies of Vietnam veterans, workers occupationally exposed to herbicides or dioxins (since dioxins contaminated the herbicide mixtures used in Vietnam), and Vietnamese populations. The article then reviews clinical issues that arise when caring for cancer patients who may have sustained Agent Orange exposure, or others concerned about such exposure to Agent Orange, such as available benefits programs and sources of information and counseling.




This article has been cited by other articles:


Home page
Toxicol PatholHome page
K. Yoshizawa, A. Heatherly, D. E. Malarkey, N. J. Walker, and A. Nyska
A Critical Comparison of Murine Pathology and Epidemiological Data of TCDD, PCB126, and PeCDF
Toxicol Pathol, December 1, 2007; 35(7): 865 - 879.
[Abstract] [Full Text] [PDF]


Home page
Armed Forces & SocietyHome page
G. A. Greenberg, R. A. Rosenheck, and R. A. Desai
Risk of Incarceration among Male Veterans and Nonveterans: Are Veterans of the All Volunteer Force at Greater Risk?
Armed Forces & Society, April 1, 2007; 33(3): 337 - 350.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVECOVER ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by American Cancer Society.